CYduct Diagnostics Inc (CYDX)

[lilpuppy6]

$$$$ Thanks for your response.

"Solos Endoscopy, Inc. Reports Significant Sales From Its MammoView® Instrument Line
In August of 2011 the company reported that there was an increase in demand for the MammoView instrument line.
Company finished the 3rd Quarter last year with a Net Profit of $73,895."

-Forecast guidance is FORWARD looking. Irrelevant past performance metric.

"We are very pleased to be supplying our MammoView® system to top cancer care and research organizations in the world. We are pleased that these hospitals have not only chosen the Solos MammoView®, but they have also chosen to re order the product multiple times," stated Bob Segersten, President of Solos Endoscopy, Inc.
From July through November, mammary ductoscopy instrument sales accounted for approximately 40% of the total sales for the period"

-Again, Forecast guidance is FORWARD looking. Irrelevant past performance metric.

As I have said. IMHO, Part of why we are seeing a steady decline, is due to investors not being impressed with lack of detailed forward looking sales/revenues guidance, except for debt reduction **yawn**. All imho. $$$$